Series of cisplatin prodrugs to inhibit fatty acid oxidation in prostate cancer

被引:0
|
作者
Kalathil, Akil [1 ]
Dhar, Shanta [1 ]
机构
[1] Univ Miami, Biochem & Mol Biol, Miami, FL USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
249
引用
收藏
页数:1
相关论文
共 50 条
  • [21] COL11A1 confers cisplatin resistance through fatty acid oxidation in ovarian cancer cells.
    Rada, Miran
    Cha, Jennifer
    Sage, Jessica
    Zhou, Bo
    Yang, Wei
    Orsulic, Sandra
    Cheon, Dong-Joo
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 45 - +
  • [22] Short-chain fatty acid-hexosamine cancer prodrugs: the sugar matters!
    Sampathkumar, Srinivasa-Gopalan
    Campbell, Christopher T.
    Weier, Christopher
    Yarema, Kevin J.
    DRUGS OF THE FUTURE, 2006, 31 (12) : 1099 - 1116
  • [23] Recognition and management of fatty acid oxidation defects: A series of 107 patients
    Saudubray, JM
    Martin, D
    de Lonlay, P
    Touati, G
    Poggi-Travert, F
    Bonnet, D
    Jouvet, P
    Boutron, M
    Slama, A
    Vianey-Saban, C
    Bonnefont, JP
    Rabier, D
    Kamoun, P
    Brivet, M
    JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (04) : 488 - 502
  • [24] Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis
    Wang, L.
    Li, W.
    Garcia, M.
    Lilly, M.
    Mercola, D.
    Martins-Green, M.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [25] Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis
    Wang, Lei
    Li, Wenfang
    Lin, Muqing
    Garcia, Monika
    Mulholland, David
    Lilly, Michael
    Martins-Green, Manuela
    CARCINOGENESIS, 2014, 35 (10) : 2321 - 2330
  • [26] Expression and function of fatty acid amide hydrolase in prostate cancer
    Endsley, Michael P.
    Thill, Rebecca
    Choudhry, Iffat
    Williams, Carol L.
    Kajdacsy-Balla, Andre
    Campbell, William B.
    Nithipatikom, Kasem
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (06) : 1318 - 1326
  • [27] The role of lipids and fatty acid metabolism in the development of prostate cancer
    Kotrikadze, Nanuli
    Alibegashvili, Manana
    Ramishvili, Liana
    Mikaia, Nino
    Khazaradze, Ana
    Sepiashvili, Bela
    Nakashidze, Irina
    Gordeziani, Manana
    Ahmad, Sarfraz
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2022, 59 (09): : 873 - 878
  • [28] Leelamine is a novel inhibitor of fatty acid synthesis in prostate cancer
    Singh, Krishna B.
    Singh, Shivendra V.
    CANCER RESEARCH, 2019, 79 (13)
  • [29] The expression and functions of fatty acid amide hydrolase in prostate cancer
    Endsley, Michael Patrick
    Isbell, Marilyn A.
    Choudhry, Iffat
    Kajdacsy-Balla, Andre
    Campbell, William B.
    Nithipatikom, Kasem
    FASEB JOURNAL, 2007, 21 (05): : A421 - A421
  • [30] Chemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy
    Sun, Bingjun
    Luo, Cong
    Cui, Weiping
    Sun, Jin
    He, Zhonggui
    JOURNAL OF CONTROLLED RELEASE, 2017, 264 : 145 - 159